Review of the recent clinical trials for PD-1/PD-L1 based lung cancer immunotherapy-Reference-Cited by-同舟云学术

Review of the recent clinical trials for PD-1/PD-L1 based lung cancer immunotherapy

Author:

Behrouzieh Sadra¹²,Sheida Fateme²³,Rezaei Nima⁴⁵⁶

Affiliation:

1. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

2. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (Usern), Tehran, Iran

3. Student Research Committee, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

4. Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

5. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

6. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (Usern), Stockholm, Sweden

Funder

funding associated with the work featured in this article

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

Reference158 articles.

1. (WHO) WHO. Global cancer observatory. Lung Cancer; 2020 [cited 2021 May 10]. Available from: https://gco.iarc.fr/

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献